Cargando…
Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
Despite the introduction of new technologies in molecular diagnostics, one should not underestimate the traditional routine methods for studying tumor DNA. Here we present the evidence that short tandem repeat (STR) profiling of tumor DNA relative to DNA from healthy cells might identify chromosomal...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952291/ https://www.ncbi.nlm.nih.gov/pubmed/35327952 http://dx.doi.org/10.3390/genes13030398 |
_version_ | 1784675578752794624 |
---|---|
author | Risinskaya, Natalya Kozhevnikova, Yana Gavrilina, Olga Chabaeva, Julia Kotova, Ekaterina Yushkova, Anna Isinova, Galina Zarubina, Ksenija Obukhova, Tatiana Kulikov, Sergey Julhakyan, Hunan Sudarikov, Andrey Parovichnikova, Elena |
author_facet | Risinskaya, Natalya Kozhevnikova, Yana Gavrilina, Olga Chabaeva, Julia Kotova, Ekaterina Yushkova, Anna Isinova, Galina Zarubina, Ksenija Obukhova, Tatiana Kulikov, Sergey Julhakyan, Hunan Sudarikov, Andrey Parovichnikova, Elena |
author_sort | Risinskaya, Natalya |
collection | PubMed |
description | Despite the introduction of new technologies in molecular diagnostics, one should not underestimate the traditional routine methods for studying tumor DNA. Here we present the evidence that short tandem repeat (STR) profiling of tumor DNA relative to DNA from healthy cells might identify chromosomal aberrations affecting therapy outcome. Tumor STR profiles of 87 adult patients with de novo Ph-negative ALL (40 B-ALL, 43 T-ALL, 4 mixed phenotype acute leukemia (MPAL)) treated according to the “RALL-2016” regimen were analyzed. DNA of tumor cells was isolated from patient bone marrow samples taken at diagnosis. Control DNA samples were taken from the buccal swab or the blood of patients in complete remission. Overall survival (OS) analysis was used to assess the independent impact of the LOH as a risk factor. Of the 87 patients, 21 were found with LOH in various STR loci (24%). For B-ALL patients, LOH (except 12p LOH) was an independent risk factor (OS hazard ratio 3.89, log-rank p-value 0.0395). In contrast, for T-ALL patients, the OS hazard ratio was 0.59 (log-rank p-value 0.62). LOH in particular STR loci measured at the onset of the disease could be used as a prognostic factor for poor outcome in B-ALL, but not in T-ALL. |
format | Online Article Text |
id | pubmed-8952291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89522912022-03-26 Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL Risinskaya, Natalya Kozhevnikova, Yana Gavrilina, Olga Chabaeva, Julia Kotova, Ekaterina Yushkova, Anna Isinova, Galina Zarubina, Ksenija Obukhova, Tatiana Kulikov, Sergey Julhakyan, Hunan Sudarikov, Andrey Parovichnikova, Elena Genes (Basel) Article Despite the introduction of new technologies in molecular diagnostics, one should not underestimate the traditional routine methods for studying tumor DNA. Here we present the evidence that short tandem repeat (STR) profiling of tumor DNA relative to DNA from healthy cells might identify chromosomal aberrations affecting therapy outcome. Tumor STR profiles of 87 adult patients with de novo Ph-negative ALL (40 B-ALL, 43 T-ALL, 4 mixed phenotype acute leukemia (MPAL)) treated according to the “RALL-2016” regimen were analyzed. DNA of tumor cells was isolated from patient bone marrow samples taken at diagnosis. Control DNA samples were taken from the buccal swab or the blood of patients in complete remission. Overall survival (OS) analysis was used to assess the independent impact of the LOH as a risk factor. Of the 87 patients, 21 were found with LOH in various STR loci (24%). For B-ALL patients, LOH (except 12p LOH) was an independent risk factor (OS hazard ratio 3.89, log-rank p-value 0.0395). In contrast, for T-ALL patients, the OS hazard ratio was 0.59 (log-rank p-value 0.62). LOH in particular STR loci measured at the onset of the disease could be used as a prognostic factor for poor outcome in B-ALL, but not in T-ALL. MDPI 2022-02-23 /pmc/articles/PMC8952291/ /pubmed/35327952 http://dx.doi.org/10.3390/genes13030398 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Risinskaya, Natalya Kozhevnikova, Yana Gavrilina, Olga Chabaeva, Julia Kotova, Ekaterina Yushkova, Anna Isinova, Galina Zarubina, Ksenija Obukhova, Tatiana Kulikov, Sergey Julhakyan, Hunan Sudarikov, Andrey Parovichnikova, Elena Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title | Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title_full | Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title_fullStr | Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title_full_unstemmed | Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title_short | Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL |
title_sort | loss of heterozygosity in the tumor dna of de novo diagnosed patients is associated with poor outcome for b-all but not for t-all |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952291/ https://www.ncbi.nlm.nih.gov/pubmed/35327952 http://dx.doi.org/10.3390/genes13030398 |
work_keys_str_mv | AT risinskayanatalya lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT kozhevnikovayana lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT gavrilinaolga lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT chabaevajulia lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT kotovaekaterina lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT yushkovaanna lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT isinovagalina lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT zarubinaksenija lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT obukhovatatiana lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT kulikovsergey lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT julhakyanhunan lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT sudarikovandrey lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall AT parovichnikovaelena lossofheterozygosityinthetumordnaofdenovodiagnosedpatientsisassociatedwithpooroutcomeforballbutnotfortall |